Expand ATHE Menu
ATHE MENU

ATHE Stock Posts


ATHE stock declines -10.2% in premarket,

Premarket Decliner

ATHE Alterity Therapeutics Limited - American Depositary Shares6.55+0.87+15.3%

Premarket:5.88-0.67 (-10.2%)

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy

Globe NewswireMon, 28-Jul 7:25 AM
ATHE stock increases 130.8% in premarket,

Premarket Gainer

ATHE Alterity Therapeutics Limited - American Depositary Shares0.58+0.01+1.8%

Premarket:1.35+0.77 (+130.8%)

Alterity Therapeutics meeting with US FDA provides development pathway for ATH434

PRNewswireMon, 29-Jun 11:14 PM
ATHE stock increases 93.8% in premarket,

Premarket Gainer

ATHE Alterity Therapeutics Limited - American Depositary Shares0.65+0.03+4.8%

Premarket:1.26+0.61 (+93.9%)

Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology

PRNewswireWed, 20-May 8:59 PM
Load Earlier Posts
Market Data Delayed 15 Minutes